XML 54 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Note 2 - Acquisitions - Preliminary Fair Value of Assets Acquired and Liabilities Assumed (Details) - USD ($)
Feb. 14, 2020
Feb. 13, 2020
Nov. 01, 2019
Dec. 31, 2020
Jun. 30, 2020
Goodwill       $ 28,090,407 $ 28,090,407
Innovus Pharmaceuticals [Member]          
Total shares issued (in shares) 3,810,393 380,000      
Estimated fair value per share of Aytu common stock (in dollars per share) $ 0.756        
Estimated fair value of equity consideration transferred $ 2,880,581        
Total consideration transferred 12,805,263        
Inventory 1,149,625        
Prepaid assets 1,692,133        
Intangible assets - product marketing rights 11,744,000 $ 11,700,000      
Accrued liabilities 7,202,309        
Total identifiable net assets 4,167,991        
Goodwill 8,637,272        
Fair value of former Innovus warrants 15,315        
Fair value of Contingent Value Rights 7,049,079 16,000,000      
Forgiveness of Note Payable owed to the Company 1,350,000        
Total consideration transferred 12,805,263        
Cash and cash equivalents 390,916        
Accounts receivable 278,826        
Other long-term assets 36,781        
Right-to-use assets 328,410        
Property, plant and equipment 190,393        
Other current liabilities 629,601        
Notes payable 3,056,361        
Lease liability $ 754,822 $ 800,000      
Innovus Pharmaceuticals [Member] | Series H Preferred Stock [Member]          
Total shares issued (in shares) 1,997,736        
Estimated fair value per share of Aytu common stock (in dollars per share) $ 0.756        
Estimated fair value of equity consideration transferred $ 1,510,288        
The Pediatric Portfolio [Member]          
Cash and cash equivalents     $ 4,500,000    
Total shares issued (in shares)     9,805,845    
Estimated fair value per share of Aytu common stock (in dollars per share)     $ 0.567    
Estimated fair value of equity consideration transferred     $ 5,559,914    
Total consideration transferred     10,059,914    
Inventory     459,123    
Prepaid assets     1,743,555    
Other current assets     2,525,886    
Intangible assets - product marketing rights     22,700,000    
Accrued liabilities     300,000    
Accrued product program liabilities     6,683,932    
Assumed fixed payment obligations     29,837,853    
Total identifiable net assets     9,393,221    
Goodwill     19,453,135    
Total consideration transferred     $ 10,059,914